DK481689A - Granuler indeholdende et laegemiddel samt fremgangsmaade til fremstilling deraf - Google Patents

Granuler indeholdende et laegemiddel samt fremgangsmaade til fremstilling deraf Download PDF

Info

Publication number
DK481689A
DK481689A DK481689A DK481689A DK481689A DK 481689 A DK481689 A DK 481689A DK 481689 A DK481689 A DK 481689A DK 481689 A DK481689 A DK 481689A DK 481689 A DK481689 A DK 481689A
Authority
DK
Denmark
Prior art keywords
pharmaceutical
particulate
medicine
procedures
preparing
Prior art date
Application number
DK481689A
Other languages
Danish (da)
English (en)
Other versions
DK481689D0 (da
Inventor
Tarlok Singh Bola
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888823082A external-priority patent/GB8823082D0/en
Priority claimed from GB898907658A external-priority patent/GB8907658D0/en
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of DK481689D0 publication Critical patent/DK481689D0/da
Publication of DK481689A publication Critical patent/DK481689A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK481689A 1988-09-30 1989-09-29 Granuler indeholdende et laegemiddel samt fremgangsmaade til fremstilling deraf DK481689A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888823082A GB8823082D0 (en) 1988-09-30 1988-09-30 New compositions of matter
GB898907658A GB8907658D0 (en) 1989-04-05 1989-04-05 New compositions of matter

Publications (2)

Publication Number Publication Date
DK481689D0 DK481689D0 (da) 1989-09-29
DK481689A true DK481689A (da) 1990-03-31

Family

ID=26294465

Family Applications (1)

Application Number Title Priority Date Filing Date
DK481689A DK481689A (da) 1988-09-30 1989-09-29 Granuler indeholdende et laegemiddel samt fremgangsmaade til fremstilling deraf

Country Status (16)

Country Link
US (1) US5489439A (ja)
EP (1) EP0361910B1 (ja)
JP (1) JPH02180813A (ja)
AT (1) ATE107854T1 (ja)
AU (1) AU623177B2 (ja)
DE (1) DE68916497T2 (ja)
DK (1) DK481689A (ja)
ES (1) ES2058546T3 (ja)
FI (1) FI894611A (ja)
HU (1) HU203967B (ja)
IE (1) IE63875B1 (ja)
IL (1) IL91836A (ja)
NO (1) NO893893L (ja)
NZ (1) NZ230836A (ja)
PT (1) PT91857B (ja)
YU (1) YU189289A (ja)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2941081B2 (ja) * 1991-03-26 1999-08-25 株式会社奈良機械製作所 結晶性有機化合物の非晶質割合の増加と再結晶化を抑制する方法
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
IL110014A (en) 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
JP3761649B2 (ja) * 1996-12-11 2006-03-29 住友化学株式会社 粒状農薬組成物の製造方法
DE19705538C1 (de) * 1997-02-14 1998-08-27 Goedecke Ag Verfahren zur Trennung von Wirkstoffen in festen pharmazeutischen Zubereitungen
US6197347B1 (en) 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
KR20130010512A (ko) 1999-10-29 2013-01-28 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
KR100960200B1 (ko) 2000-10-30 2010-05-27 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
UA81224C2 (uk) 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
MY148466A (en) * 2001-10-26 2013-04-30 Merck Frosst Canada Ltd Granule formulation
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US7118765B2 (en) * 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
CA2480826C (fr) 2002-04-09 2012-02-07 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
KR100466637B1 (ko) * 2003-06-26 2005-01-13 주식회사 펩트론 서방성 미립구의 혼합 제형을 연속한 단일 공정으로제조하는 방법
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE602006007538D1 (de) * 2005-01-06 2009-08-13 Cima Labs Inc Geschmacksunterdrückungssystem für nicht geweichte arzneimittel
RU2007143556A (ru) * 2005-04-25 2009-06-10 ТЕВА ФАРМАСЬЮТИКАЛЗ ЮЭсЭй, ИНК. (US) Композиции с пролонгированным высвобождением
US9023400B2 (en) * 2006-05-24 2015-05-05 Flamel Technologies Prolonged-release multimicroparticulate oral pharmaceutical form
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
US20080069871A1 (en) * 2006-07-21 2008-03-20 Vaughn Jason M Hydrophobic abuse deterrent delivery system
EP1972336A1 (en) * 2007-03-19 2008-09-24 LEK Pharmaceuticals D.D. Hot-melt micropellets
ATE515259T1 (de) * 2007-05-29 2011-07-15 Lek Pharmaceuticals Pharmazeutische zusammensetzung mit eszopiclon
MX2011009053A (es) * 2009-03-09 2012-04-02 Spi Pharma Inc Excipientes de compresion directa con alta capacidad de compactacion y durables y sistemas de excipiente.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
PE20181177A1 (es) 2010-12-22 2018-07-20 Purdue Pharma Lp Formas de dosis de liberacion controlada encerradas resistentes a manipulaciones indebidas
CN103327969A (zh) 2010-12-23 2013-09-25 普渡制药公司 抗篡改固体口服剂型
JP6255908B2 (ja) * 2012-11-09 2018-01-10 大正製薬株式会社 固形製剤
EA201500742A1 (ru) 2013-02-05 2015-12-30 Пердью Фарма Л.П. Защищенные от нецелевого использования фармацевтические композиции
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2793979A (en) * 1953-03-30 1957-05-28 Smith Kline French Lab Method of making a sustained release pharmaceutical tablet and product of the method
DE2028224A1 (de) * 1969-06-10 1970-12-17 Solco Basel AG, Basel (Schweiz)j Oral anwendbare Arzneimittelform
GB1509979A (en) * 1975-11-28 1978-05-10 Fisons Ltd Pharmaceutical compositions containing aspirin or indomethacin
EP0094116A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
US4743247A (en) * 1984-08-13 1988-05-10 Alza Corporation Process for manufacturing dosage form
AT385654B (de) * 1984-09-04 1988-05-10 Arcana Chem Pharm Verfahren zur herstellung von oelhaeltigen zubereitungen in granulatform zur oralen verabreichung
EP0192321A3 (en) * 1985-01-19 1987-09-02 Beecham Group Plc Enteric coated allergen pharmaceutical composition
EP0205336B1 (en) * 1985-06-11 1991-09-11 Teijin Limited Oral sustained release pharmaceutical preparation

Also Published As

Publication number Publication date
DE68916497T2 (de) 1994-11-17
NZ230836A (en) 1990-07-26
HUT53282A (en) 1990-10-28
EP0361910A1 (en) 1990-04-04
FI894611A (fi) 1990-03-31
HU203967B (en) 1991-11-28
US5489439A (en) 1996-02-06
DE68916497D1 (de) 1994-08-04
NO893893L (no) 1990-04-02
FI894611A0 (fi) 1989-09-28
JPH02180813A (ja) 1990-07-13
PT91857A (pt) 1990-03-30
ATE107854T1 (de) 1994-07-15
DK481689D0 (da) 1989-09-29
NO893893D0 (no) 1989-09-29
IE893132L (en) 1990-03-30
IL91836A0 (en) 1990-06-10
YU189289A (en) 1991-04-30
PT91857B (pt) 1995-07-03
ES2058546T3 (es) 1994-11-01
AU623177B2 (en) 1992-05-07
EP0361910B1 (en) 1994-06-29
IE63875B1 (en) 1995-06-14
AU4241689A (en) 1990-04-05
IL91836A (en) 1994-12-29

Similar Documents

Publication Publication Date Title
DK481689A (da) Granuler indeholdende et laegemiddel samt fremgangsmaade til fremstilling deraf
DK108888A (da) Farmaceutisk tablet, farmaceutisk granulat og fremgangsmaader til fremstilling af henholdsvis denne tablet og dette granulat
GR930100245A (el) Παρασκευή γκρανουλέ δια περιστροφής πήγματος.
NO175287C (no) Fremgangsmåte for fremstilling av et intravenöst, farmasöytisk preparat
DK407588D0 (da) Oxadiazolforbindelse, farmaceutisk praeparat indeholdende en saadan forbindelse, anvendelse af forbindelsen til fremstilling af et laegemiddel samt fremgangsmaade til fremstilling af en saadan forbindelse
PT86819A (pt) Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same
NO891509L (no) Innretning for kontrollert frigivelse av nikotin, fremgangsmaate for dens fremstilling og anvendelse derav.
NO882002D0 (no) Fremgangsmaate for fremstilling av sfaeriske partikler.
NZ222110A (en) Therapeutic powder form of spray-dried acetaminophen which includes ethyl cellulose and colloidal silica, and solid pharmaceutical dosage forms comprising the powder
DE3866033D1 (de) Arzneizubereitungen mit mikronisierten ebselen-kristallen.
DK0391374T3 (da) Fremgangsmåde til fremstilling af farmaceutiske præparater med høj stabilitet indeholdende bromocriptin, samt hertil svarende produkter
IE872752L (en) Spray-dried acetaminophen(paracetamol)
PT87243A (pt) Process for the preparation of aliphatic carboxamides and of pharmaceutical compounds containing them
DK246985A (da) Triterpenylestere af organiske syrer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende saadanne triterpenylestere
SE8800080D0 (sv) Lekemedelskomposition
DK170788D0 (da) Dihydropyridazinonderivater, fremgangsmaader til fremstilling heraf samt laegemidler indeholdende disse
NO177598C (no) Fremgangsmåte for fremstilling av fine polymerpartikler med ensartet störrelse
DK0381174T3 (da) Fremgangsmåde til fremstilling af faste farmaceutiske præparater
DK194388A (da) Guanidincarboxylsyreestere, fremgangsmaade til fremstilling heraf samt laegemidler indeholdende disse forbindelser
PT87593A (pt) Process for the preparation of nucleosides and of pharmaceutical compounds containing them
PT87573A (pt) Process for the preparation of amidas pyrazine and of pharmaceutical compounds containing them
PT87781A (pt) Process for the preparation of 8 alpha-acylamino ergoline and of pharmaceutical compounds containing them
NO172576C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-(fluoralkylen)-5-hydroxytryptofan-derivater
DK659389A (da) Fremgangsmaade til fremstilling af et tabletterbart granulat
NO883285L (no) Fremgangsmaate til fremstilling av leukotrienantagonister.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment